Description

BSE announces listing of 1,500 Commercial Papers of KEC International Ltd. worth Rs. 5,00,000 each on private placement basis, effective December 8, 2025.

Summary

BSE has listed new Commercial Papers issued by KEC International Ltd. on private placement basis effective December 8, 2025. The listing includes 1,500 securities of face value Rs. 5,00,000 each on the BSE Debt segment. The instruments carry CRISIL A1+ and IND A1+ credit ratings and will mature on March 6, 2026.

Key Points

  • Issuer: KEC International Ltd.
  • Instrument Type: Commercial Paper (Private Placement)
  • Quantity: 1,500 units
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,596.50 per unit
  • Total Issue Size: Rs. 75 crores
  • Scrip Code: 730716
  • Scrip ID: KIL81225
  • ISIN: INE389H14LR8
  • Credit Rating: CRISIL A1+, IND A1+
  • Market Lot: 1 unit
  • Issuing and Paying Agent: Axis Bank Limited

Regulatory Changes

No regulatory changes. This is a standard listing notification.

Compliance Requirements

  • Trading members must note that securities will be traded only in dematerialized form under ISIN INE389H14LR8
  • Trading shall take place in standard denomination of Rs. 5 Lakhs and multiples thereof
  • Tick size for the securities is 1 paise
  • Securities are available for trading on the BSE Debt segment

Important Dates

  • Listing Date: December 8, 2025
  • Allotment Date: December 8, 2025
  • Redemption Date: March 6, 2026
  • Tenure: 88 days (approximately 3 months)

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The listing provides KEC International Ltd. with short-term funding through the debt capital markets. The high credit ratings (A1+) indicate strong creditworthiness. The listing expands the BSE Debt segment’s instrument base but does not affect equity markets or broader trading operations. Only relevant for debt market participants and investors interested in short-term corporate debt instruments.

Impact Justification

Routine listing of commercial paper on private placement basis with no broader market implications